Lisata Therapeutics (LSTA) 10-K2021 FY Annual report

Filed: 22 Mar 22, 4:10pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: aspect, breadth, burden, Clearance, Cognate, comfortable, conflict, counter, coupled, criterion, cultivate, curtailed, devising, diabetic, diversify, DKD, DSMB, dynamic, embrace, endothelial, entrepreneurial, explicitly, exploration, explore, exploring, fashion, feel, fierce, filtration, forfeited, forward, gender, geographic, geopolitical, glomerular, grace, hacking, heavily, ID, incentivizing, indefinitely, invasion, iv, learning, leverage, merger, military, mission, month, motivate, motivating, nondiscrimination, notify, pause, persisted, philosophy, preemptive, progenitor, proud, race, ransomware, reestablished, reimplemented, religion, reward, River, robust, Russian, sexual, stipulated, strongly, Ukraine, unutilized, vaccination, vision, weaken, weakening, write, writing, wrote, XOWNA

Removed: abolished, AIA, behalf, Biomedical, capitalization, Circuit, derivation, disabling, encouraging, FBRI, FDC, instituting, interference, invent, invention, inventor, inventorship, Kobe, lapsed, newly, NORDA, opposition, planning, published, reached, refractory, superseded, validity

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated LSTA transcripts

LSTA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have issued our report dated March 22, 2022, with respect to the consolidated financial statements included in the Annual Report of Caladrius Biosciences, Inc. on Form 10-K for the year ended December 31, 2021. We consent to the incorporation by reference of said report in the Registration Statements of Caladrius Biosciences, Inc. on Form S-1 (File No 333-239302), Forms S-3 (File No. 333-196702, File No. 333-206175, File No. 333-210664, File No. 333-214607, File No. 333-220354, File No. 333-226319, File No. 333-248100, and File No. 333-252560) and on Forms S-8 (File No. 333-107438, File No. 333-144265, File No. 333-159282, File No. 333-162733, File No. 333-173854, File No. 333-181365, File No. 333- 184927, File No. 333-191572, File No. 333-205662, File No. 333-212202, File No. 333-215455, File No. 333-218642, File No. 333-222410, File No. 333-225743, File No. 333-225744, File No. 333-248101, File No. 333-257560, and File No. 333-254971).

/s/GRANT THORNTON LLP

New York, New York

March 22, 2022